Modeling vaccination coverage during the 2022 central Ohio measles outbreak: a cross-sectional study.
Modeling vaccination coverage during the 2022 central Ohio measles outbreak: a cross-sectional study.
复制标题
DOI:
10.1016/j.lana.2023.100533
复制
发表时间:
2023-07
期刊:
影响因子:
--
通讯作者:
Majumder, Maimuna S.
中科院分区:
文献类型:
--
作者:
Martoma, Rosemary A.;Washam, Matthew;Martoma, Joshua C.;Cori, Anne;Majumder, Maimuna S.
关键词:
Of the eight large (>50 cases) US postelimination outbreaks, the first and last occurred in Ohio. Ohio's vaccination registry is incomplete. Community-level immunity gaps threaten more than two decades of measles elimination in the US. We developed a statistical model, VaxEstim, to rapidly estimate the early-phase vaccination coverage and immunity gap in the exposed population during the 2022 Central Ohio outbreak. We used reconstructed daily incidence (from publicly available data) and assumptions about the distribution of the serial interval, or the time between symptom onset in successive measles cases, to estimate the effective reproduction number (i.e., the average number of secondary infections caused by an infected individual in a partially immune population). We estimated early-phase measles vaccination coverage by comparing the effective reproduction number to the basic reproduction number (i.e., the average number of secondary infections caused by an infected individual in a fully susceptible population) while accounting for vaccine effectiveness. Finally, we estimated the early-phase immunity gap as the difference between the estimated critical vaccination threshold and vaccination coverage. VaxEstim estimated the early-phase vaccination coverage as 53% (95% credible interval, 21%–77%), the critical vaccination threshold as 93%, and the immunity gap as 42% (95% credible interval, 18%–74%). This study estimates a significant immunity gap in the exposed population during the early phase of the 2022 Central Ohio measles outbreak, suggesting a robust public health response is needed to identify the susceptible community and develop community-specific strategies to close the immunity gap. This work was supported in part by the , ; the (MRC); the ; the (NIHR) ; , and the , Community Jameel; the EDCTP2 programme, supported by the ; and the .
登录
查看更多内容
DOI:
10.1093/infdis/jiaa793
发表时间:
2021-09-30
期刊:
The Journal of infectious diseases
影响因子:
--
作者:
Gastañaduy PA;Goodson JL;Panagiotakopoulos L;Rota PA;Orenstein WA;Patel M
通讯作者:
Patel M
影响因子:
11.8
作者:
Delamater, Paul L.;Street, Erica J.;Jacobsen, Kathryn H.
通讯作者:
Jacobsen, Kathryn H.
影响因子:
33.9
作者:
McDonald, Robert;Ruppert, Patricia Schnabel;Zucker, Howard A.
通讯作者:
Zucker, Howard A.
影响因子:
158.5
作者:
Gastanaduy, Paul A.;Budd, Jeremy;DiOrio, Mary
通讯作者:
DiOrio, Mary
影响因子:
11.8
作者:
Mathis, Adria D.;Clemmons, Nakia S.;Gastanaduy, Paul A.
通讯作者:
Gastanaduy, Paul A.